Related Experiment Video

Updated: Dec 28, 2025

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
08:23

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Published on: November 29, 2019

11.5K

Corrigendum to Serum hepcidin levels in multiple sclerosis

    Multiple Sclerosis Journal - Experimental, Translational and Clinical
    |February 18, 2020
    PubMed

    More Related Videos

    Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques11:28

    Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

    Published on: March 13, 2015

    41.3K
    Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis08:40

    Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

    Published on: February 28, 2021

    4.4K

    Related Concept Videos

    Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

    Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

    Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
    196